• Reversine: Advancing Aurora Kinase Inhibition in Cancer Rese

  2026-07-18

  This thought-leadership article synthesizes mechanistic insights into Aurora kinase signaling, the evolving role of mitotic checkpoint modulation, and strategic recommendations for translational researchers leveraging Reversine. Bridging foundational biology with actionable guidance, it positions Reversine as a uniquely potent research tool for dissecting cell cycle control and cancer cell proliferation.

• Propidium Iodide: Precision DNA Intercalating Dye for Advanc

  2026-07-17

  Propidium iodide (PI) stands apart as an essential DNA intercalating dye for distinguishing viable, apoptotic, and necrotic cells with high fidelity in fluorescence-based assays. This article translates leading-edge research and hands-on troubleshooting into actionable guidance, empowering users of APExBIO’s PI for next-generation cell viability, apoptosis, and cell cycle workflows.

• β-Elemene Inhibits Adipogenesis via AMPK Pathway Activation

  2026-07-17

  This study demonstrates that β-Elemene suppresses adipogenesis in 3T3-L1 cells by activating the AMPK pathway and reversing insulin resistance. The findings highlight β-Elemene’s potential as a research tool for dissecting metabolic regulation and anti-obesity mechanisms.

• DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution

  2026-07-16

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution addresses the need for reliable, ready-to-use nuclear staining in fixed or membrane-compromised mammalian cell samples. Its application is optimal for fluorescence microscopy and flow cytometry workflows but is not suitable for live-cell imaging due to limited membrane permeability.

• TRPV1+ Nerve Stimulation Suppresses Systemic Inflammation vi

  2026-07-16

  Song et al. (2025) detail how targeted activation of TRPV1+ peripheral somatosensory nerves suppresses systemic inflammation through a somato-autonomic reflex. This neural-immune pathway rapidly modulates catecholamine secretion and splenic gene expression, providing mechanistic insight for anti-inflammatory intervention strategies.

• Zbp1 Drives Atherosclerotic Lesion Necrosis via Necroptosis

  2026-07-15

  This study establishes Zbp1 as a key genetic modifier of atherosclerosis in mice, demonstrating that Zbp1 knockout reduces both lesion size and necrotic core formation. The findings illuminate the mechanistic role of Zbp1-mediated necroptosis in vascular inflammation, offering new perspectives for targeting regulated cell death in cardiovascular research.

• Chenodeoxycholic Acid: FXR Activation in Renal and Metabolic

  2026-07-15

  Chenodeoxycholic Acid (CDCA) is a primary bile acid and potent FXR agonist with validated effects in cholesterol metabolism research and kidney injury models. CDCA directly activates the FXR-KLF11 axis, suppressing JAK2/STAT3-mediated inflammation and apoptosis. This article summarizes up-to-date mechanistic, protocol, and application insights for CDCA in metabolic and renal signaling studies.

• Bufalin: Applied Cardiotoic Steroid Protocols for Cancer Res

  2026-07-14

  Bufalin, a potent cardiotonic steroid, is redefining experimental cancer research by enabling targeted STK33 degradation and robust apoptosis induction. This article translates novel bench findings into actionable protocols, troubleshooting strategies, and comparative insights, empowering oncology labs to unlock Bufalin's full potential in triple-negative breast cancer and beyond.

• MLN4924 HCl Salt: Decoding NEDD8 Pathway Inhibition in Viral

  2026-07-14

  Explore how MLN4924 HCl salt, a potent NEDD8-activating enzyme inhibitor, unveils new strategies for dissecting host-pathogen interactions and protein degradation in disease models. This article uniquely integrates mechanistic virology and assay optimization for advanced research.

• Imipenem in Advanced Antibacterial Research: Practical Guida

  2026-07-13

  This article provides a scenario-driven, evidence-based guide for biomedical researchers and lab scientists leveraging Imipenem (SKU P10075) in cell viability, proliferation, and cytotoxicity assays. Emphasizing reproducibility and immune response modulation, we illustrate how APExBIO's Imipenem offers robust, validated solutions for common experimental challenges.

• Gemcitabine in Precision Apoptosis Assays: Protocols, Mechan

  2026-07-13

  Explore the advanced use of Gemcitabine as a DNA synthesis inhibitor in apoptosis and DNA damage response assays. This article offers a unique, protocol-driven perspective for cancer research, integrating recent transcriptomic insights to inform experimental design.

• Alda 1: ALDH2 Activator for Advanced Cardiac and Dermatitis

  2026-07-12

  Alda 1, a potent ALDH2 activator from APExBIO, enables breakthrough workflows in cardiac ischemia and radiation-induced dermatitis models. Its unique ability to restore ALDH2*2 variant activity and deliver robust cardioprotection makes it a pivotal tool for researchers advancing regenerative and protective strategies in oxidative stress and aldehyde detoxification.

• Gastrin I (human): Unlocking Translational GI Research Model

  2026-07-10

  Explore how human Gastrin I peptide empowers advanced translational research, bridging mechanistic insight with strategic guidance in gastrointestinal physiology and pharmacokinetic modeling. This article integrates evidence from hiPSC-derived organoid systems and highlights APExBIO’s Gastrin I (human) as a next-generation tool for GI disorder studies.

• ASB3 E3 Ligase Negatively Regulates Antiviral Immunity via M

  2026-07-09

  This study identifies ASB3 as a previously uncharacterized E3 ubiquitin ligase that inhibits antiviral innate immunity by promoting K48-linked polyubiquitination and proteasomal degradation of MAVS. These findings reveal a new regulatory axis modulating type I interferon responses and highlight the complexity of host-virus interactions.

• FAISL lncRNA Blocks Calpain-2 FAK Cleavage in TNBC Progressi

  2026-07-09

  This study uncovers how the long non-coding RNA FAISL promotes triple negative breast cancer (TNBC) progression by inhibiting calpain-2-mediated proteolysis of focal adhesion kinase (FAK), stabilizing FAK protein and enhancing tumor aggressiveness. The findings highlight a novel lncRNA-driven mechanism of protease regulation in cancer and suggest new avenues for targeted therapy.

451 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page